Skip to main content

Peer Review reports

From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

Original Submission
25 Oct 2015 Submitted Original manuscript
22 Feb 2016 Author responded Author comments - Kenji Nakano
12 Jan 2016 Reviewed Reviewer Report - Zhanwei Wang
Resubmission - Version 2
22 Feb 2016 Submitted Manuscript version 2
4 Apr 2016 Author responded Author comments - Kenji Nakano
1 Mar 2016 Reviewed Reviewer Report - Zhanwei Wang
Resubmission - Version 3
4 Apr 2016 Submitted Manuscript version 3
15 May 2016 Author responded Author comments - Kenji Nakano
Resubmission - Version 4
15 May 2016 Submitted Manuscript version 4
1 Jul 2016 Author responded Author comments - Kenji Nakano
Resubmission - Version 5
1 Jul 2016 Submitted Manuscript version 5
23 Jul 2016 Author responded Author comments - Kenji Nakano
Resubmission - Version 6
23 Jul 2016 Submitted Manuscript version 6
27 Aug 2016 Author responded Author comments - Kenji Nakano
Resubmission - Version 7
27 Aug 2016 Submitted Manuscript version 7
Publishing
15 Sep 2016 Editorially accepted
23 Sep 2016 Article published 10.1186/s12885-016-2786-z

You can find further information about peer review here.

Back to article page